IRCT201405217513N10
Completed
Phase 3
Comparison of Metformin, Flutamide + oral contraceptives and Simvastatin Effects on Metabolic complications of Polycystic Ovary Syndrome
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Polycystic Ovary Syndrome.
- Sponsor
- Isfahan University of Medical Sciences
- Enrollment
- 111
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •age \= 18 years; being single; having no evidence for thyroid dysfunction, Cushing syndrome, and hyperprolactinaemia; to have normal kidney function, bilirubin level, and serum aminotransferases; none\-smoker; not having breast cancer; not using any drug which probably affects the Ovarian function; insulin sensitivity and lipid profile; No contraindication to use drugs.
- •Exclusion criteria:
- •to refuse to continue the study; marriage; emerging side drugs effects or contraindication;
- •not to comply the study protocol.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Comparing the effects of metformin versus combined Contraceptive pills in adolescent PCOSPACTR201307000567163Hassan Aly Hassan Elmaghraby120
Completed
Phase 3
Effect of Flutamide and Metformin administered in dieting overweight-obese women with polycystic ovary syndromePolycistic overian syndrome.Polycistic overian syndromeIRCT138807271760N3Vice Chancellor for Research and Technology, Babol University of Medical Sciences80
Completed
Phase 3
Comparison effect of Metformin and combination of acid folic and myo-inositol in poly cystic ovary syndromeIRCT20201219049758N1Tehran University of Medical Sciences140
Not yet recruiting
Not Applicable
Comparative study the use of metformin versus placebo for prophylaxis from gestational diabetes in high risk patientsNutritional, Metabolic, EndocrinePregnancy and Childbirthgestational diabetesPACTR201503001059248Tamer Mamdouh Abdel Dayem300
Recruiting
Phase 3
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220822055771N1Shahre-kord University of Medical Sciences50